AKT1 and obesity disorder: Our study provides evidence that drugs that normalize intracellular Ca2+ homeostasis can ameliorate insulin resistance by rescuing impaired phosphorylation of AKT, an essential kinase for insulin signaling, and its downstream signaling molecules in the setting of obesity and hyperlipidemia.